SAN FRANCISCO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY, founded in 2004, is a small nonprofit in the Science & Technology sector that reported $230K in total revenue in fiscal year 2023. Revenue surged 55% from the prior year, signaling strong growth momentum.
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professional in the biopharmaceutical industry. CABS is highly influential association with more than 3,000 members and subscribers in the life science industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life science corporations. We organize many activities to promote international collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in the Pacific Rim with an excellent platform to promote business and to recruit talent. CABS is helping members seeking collaboration opportunities in the Pacific Rim. To further meet the needs of CABS members, we are actively helping our members seeking partnership opportunities in the Pacific Rim:To co-sponsor scientific conference in biopharmaceutical fieldTo organize C
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $230,254 | $148,904 | +0.5% |
| Expenses | $244,893 | $149,773 | +0.6% |
| Net Income | $-14,639 | $-869 | +15.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Yan Wang | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Alan Hao | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Cheni Kwok | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Alex Zhang | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Jessica Sun | President & Dir | 7.00 |
Officer
Director
|
$0 | $0 | $0 |
| Yuying Kate You | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| JINGSHAN HU | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Carrie Wang | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Wei Dong | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| JANET XIAO | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| WENTAO ZHANG | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| ZHONGHUA PEI | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Kay Tong | President Elect | 2.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $230,254 | $244,893 | $290,662 | $-14,639 |
Compare CHINESE-AMERICAN BIOPHARMACEUTICAL SOCIETY with other nonprofits in California and across the country.